The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer.

Long JiangJia HuangShanshan JiangWenwen RongYaofeng ShenChongwu LiYu TianJunwei NingXiaoke ChenYunhai YangZhengping DingZiming LiQingquan Luo

Published in: Cancer immunology, immunotherapy : CII (2021)

Pulmonary resection after neoadjuvant immunotherapy or chemo-immunotherapy for resectable NSCLC appears to be safe with low operative mortality and morbidity rate in the current population.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
radiation therapy
lymph node
small cell lung cancer
cardiovascular events
photodynamic therapy
liver metastases
type diabetes
cancer therapy
coronary artery disease